FDA Says Shortage of GLP-1 Tirzepatide Is Over
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
Antibiotic Use Not Linked to Incident Dementia, Cognitive Impairment
No association seen for increased risks for dementia, cognitive impairment without dementia, accelerated cognitive decline
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
The monoclonal antibody treatment is for patients ages 12 years and older
RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults
Vaccine effectiveness 91 percent using strict controls in a population of adults aged 60 years or older
USPSTF Recommends Against Vitamin D Supplementation for Fracture, Fall Prevention
Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors
β-Blocker Use Delays Motor Onset With Huntington Disease
β-blocker use also tied to reduced rate of worsening of symptoms in early motor-manifest disease
Serious Complications Seen With Acetaminophen Use in Seniors
Risks increased for peptic ulcer bleeding, uncomplicated peptic ulcer, lower GI bleeding, heart failure, HTN, CKD
Empagliflozin Not Tied to Risk for New Nonproliferative Diabetic Retinopathy
Empagliflozin may lower risk for diabetic retinopathy progression
Poststroke Epilepsy Risk Varies With Antihypertensive Treatment
Risk for PSE was lower for patients treated with ARBs and higher for those receiving calcium channel blockers, beta-blockers
